Issued Patents All Time
Showing 1–25 of 35 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12397029 | Use of MVA or MVADELTAE3L as immunotherapeutic agents against solid tumors | Liang Deng, Taha Merghoub, Stewart Shuman, Peihong Dai, Weiyi Wang | 2025-08-26 |
| 12331359 | Neoantigens and uses thereof for treating cancer | Marta Luksza, Vinod P. Balachandran, Arnold J. Levine, Taha Merghoub, Steven D. Leach +3 more | 2025-06-17 |
| 12252702 | Recombinant poxviruses for cancer immunotherapy | Liang Deng, Stewart Shuman, Taha Merghoub, Ning-Sun Yang, Yi WANG +3 more | 2025-03-18 |
| 12246066 | Anti-CTLA-4 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Taha Merghoub +7 more | 2025-03-11 |
| 12042534 | Newcastle disease viruses and uses thereof | Peter Palese, Adolfo Garcia-Sastre, Dmitriy Zamarin | 2024-07-23 |
| 12036279 | Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors | Liang Deng, Stewart Shuman, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2024-07-16 |
| 11993653 | Antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Taha Merghoub +8 more | 2024-05-28 |
| 11986503 | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy | Liang Deng, Stewart Shuman, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2024-05-21 |
| 11884939 | Vaccinia virus mutants useful for cancer immunotherapy | Liang Deng, Stewart Shuman, Ning-Sun Yang, Taha Merghoub | 2024-01-30 |
| 11638755 | Anti-CTLA-4 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Taha Merghoub +7 more | 2023-05-02 |
| 11541087 | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy | Liang Deng, Stewart Shuman, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2023-01-03 |
| 11426460 | Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors | Liang Deng, Stewart Shuman, Taha Merghoub, Peihong Dai, Weiyi Wang | 2022-08-30 |
| 11401335 | Anti-GITR antibodies and methods of use thereof | Ana M. GONZALEZ, Nicholas Stuart Wilson, Dennis John Underwood, Volker Seibert, Olivier Leger +6 more | 2022-08-02 |
| 11345755 | Anti-PD-1 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, Taha Merghoub, Roberta Zappasodi +4 more | 2022-05-31 |
| 11285209 | Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors | Liang Deng, Stewart Shuman, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2022-03-29 |
| 11267889 | Anti-CTLA-4 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Taha Merghoub +2 more | 2022-03-08 |
| 11253560 | Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors | Liang Deng, Taha Merghoub, Stewart Shuman, Peihong Dai, Weiyi Wang | 2022-02-22 |
| 11242509 | Vaccinia virus mutants useful for cancer immunotherapy | Liang Deng, Stewart Shuman, Ning-Sun Yang, Taha Merghoub | 2022-02-08 |
| 11045506 | Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitis | Eric Pamer, Krista Dubin | 2021-06-29 |
| 11013802 | Anti-CTLA-4 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Taha Merghoub +7 more | 2021-05-25 |
| 10912831 | Anti-CTLA-4 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Taha Merghoub +7 more | 2021-02-09 |
| 10800849 | Anti-GITR antibodies and methods of use thereof | Ana M. GONZALEZ, Nicholas Stuart Wilson, Dennis John Underwood, Volker Seibert, Olivier Leger +6 more | 2020-10-13 |
| 10765711 | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy | Liang Deng, Stewart Shuman, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2020-09-08 |
| 10736962 | Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors | Liang Deng, Stewart Shuman, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2020-08-11 |
| 10639366 | Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors | Liang Deng, Stewart Shuman, Taha Merghoub, Peihong Dai, Weiyi Wang | 2020-05-05 |